Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
Hideo ShichinoheMasahito KawaboriHiroaki IijimaTuyoshi TeramotoTakeo AbumiyaNaoki NakayamaKen KazumataShunsuke TerasakaTeruyo AratoKiyohiro HoukinPublished in: BMC neurology (2017)
The trial was registered at The University Hospital Medical Information Network on February 22, 2017 (UNIN ID: UMIN000026130 ). The findings of this trial will be disseminated to patients and through peer-reviewed publications and international presentations.
Keyphrases
- bone marrow
- phase iii
- phase ii
- acute ischemic stroke
- open label
- study protocol
- clinical trial
- stem cells
- mesenchymal stem cells
- end stage renal disease
- cell therapy
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- newly diagnosed
- healthcare
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- radiation therapy
- phase ii study
- patient reported
- health information
- network analysis